bionity.com News

Nuvisan  announced it has received a US$25 million grant from the Gates Foundation to advance a portfolio of novel non-hormonal contraceptive drug discovery projects.   The new three-year grant builds on a successful program, delivered over the past three years. It is intended to further expand the ...

Many of the deadliest forms of cancer are caused by a pathological mutation in the RAS protein. Yet, to date, no effective treatment for this cancer protein has been found. A new research approach aims to prevent the protein from forming in the first place by destroying its blueprint – the mRNA. Bas...

A new AI model has become so good at predicting how molecules evolve over time that, in the future, it could speed up the costly and time-consuming process of testing new drugs. In the long term, this technology could facilitate the development of medicines and new treatments, as promising drug cand...

Axplora announced the strategic consolidation of ursodeoxycholic acid (UDCA) manufacturing at its Vizag, India site, part of the PharmaZell business unit. Production will transition fully from the company’s Gropello Cairoli, Italy site — the renowned manufacturing site within the Farmabios business ...

Experts in Heidelberg have developed an AI system that can classify brain tumors with unprecedented accuracy using standard microscopic tissue sections. Using digitized standard stains, the system identifies more than 100 molecular subtypes of central nervous system tumors, delivers results within m...

GSK plc announced that it has entered an agreement to acquire Nuvalent, Inc. a Boston-based clinical-stage biopharmaceutical company focused on creating precisely targeted oncology therapies, for $10.6 billion. The acquisition is consistent with GSK’s strategy of acquiring assets that have validated...

Ceva Animal Health, the world's fifth largest animal health company announces the acquisition ofAquilón CyL S.L., a Spanish biotechnology company specialised in research, diagnostics, and the development of innovative biological solutions for swine diseases. Founded in 2012 and based in León – Spain...

For the first half of the current fiscal year (ended March 31, 2026), the ZEISS Group reported slight revenue growth, with revenue totaling 5.841 billion euros (prior year: 5.794 billion euros, up 1%). Earnings before interest and taxes (EBIT) amounted to 955 million euros (up 33 million euros). The...

Despite challenging market conditions, Germany’s biotech companies raised a total of 1.8 billion euros in capital in 2025—a 5 percent decrease from the previous year, when the total stood at 1.9 billion euros. Venture capital investments also declined in 2025 compared to the previous year, falling f...

A research team has uncovered a previously unknown RNA-based control system that helps tea plants regulate amino acid production, a process central to tea flavor, nutritional value, and quality. The study reveals how a long non-coding RNA (lncRNA), named lncR12304.1, acts as a molecular sponge for m...

A research team from Forschungszentrum Jülich has won the international “Metascience Novelty Indicators Challenge”. The scientists at Jülich Systems Analysis developed a method that enables artificial intelligence to assess the novelty of scientific publications – in other words, the extent to which...

Multi-million-euro funding from the European Union: Congenital heart defects often lead to heart failure. This means that even young patients require mechanical circulatory support or an organ transplant. Both severely impair quality of life. Heart muscle cells grown in the laboratory offer an alter...

IMU Biosciences, a biotechnology company decoding the immune system to pioneer a paradigm shift in how we understand, diagnose and treat disease, has successfully brought its Series A to over $53 million (£40 million) in an oversubscribed financing round, co-led by IQ Capital and Molten Ventures, an...

Researchers at the Helmholtz Institute for One Health (HIOH) have demonstrated that larvae of the greater wax moth (Galleria mellonella) are suitable as an alternative infection model for investigating the pathogenicity of bacteria on a larger scale. This could significantly reduce animal testing on...

New Nature Communications study reveals how bacteria stockpile and recycle nutrients by employing extracellular vesicles (EVs) as a flexible deposit to survive periods of starvation. Bacteria as tiny economies Bacteria do more than invade and infect – they also handle resources with remarkable fines...

Merck announced the appointments of Clara Sattler de Sousa e Brito as Head of Discovery Solutions and Robert Machinek as Head of Strategy & Business Development for the company’s Life Science business. Sattler de Sousa e Brito will assume her role in the third quarter of 2026 and Machinek assumes hi...

Researchers from ETH Zurich have developed an active ingredient that slows down the progression of typical Alzheimer’s symptoms in mice. This new substance protects nerve cells and could in future alleviate the suffering of Alzheimer’s patients. The active ingredient also shows anti-ageing effects. ...

Bacteria also produce molecules with an antiviral effect. Researchers at Heinrich Heine University Düsseldorf (HHU) and Forschungszentrum Jülich (FZJ), together with colleagues from Marburg and Zurich, have investigated the antiviral molecule daunorubicin and deciphered its mode of action against vi...

Concerns about the health effects of ultra-processed foods are growing, as studies increasingly link them to conditions such as heart disease, diabetes, and even early death. But scientists are still debating what’s driving those risks: the nutritional quality of these foods—which are often high in ...

As part of the "EXIST Research Transfer" program, two start-ups from Mannheim University of Applied Sciences will receive funding from the Federal Ministry for Economic Affairs and Energy in the amount of one million euros each over the next two years. The two funded start-ups are LiberaZell and Sap...